David Ware
Family Medicine · Findlay, OHNPI 1760445084
Payments from drug & device makers
Across 347 payments — averaging $10.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$812
- AbbVie$480
- Sanofi-aventis U.S. LLC$376
- Merck$269
- Amgen$252
- Pfizer$240
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,68599%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 108 | $812 |
| AbbVie(2 entities) | 59 | $480 |
| Sanofi-aventis U.S. LLC | 25 | $376 |
| Merck | 28 | $269 |
| Amgen | 21 | $252 |
| Pfizer | 20 | $240 |
| AstraZeneca | 11 | $237 |
| Lilly USA, LLC | 12 | $164 |
| Amarin Pharma, Inc. | 9 | $133 |
| Bayer | 15 | $119 |
| Kowa Pharmaceuticals America, Inc. | 7 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Boehringer Ingelheim | 5 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $72 |
| Abbott | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Mannkind Corporation | 1 | $23 |
| Exact Sciences | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| GSK | 1 | $15 |
| Astellas Pharma US Inc | 1 | $13 |
| Gilead | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
How this compares
$3,719 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $7,194 |
| Rosuvastatin Calcium | 26 | $386 |
| Amlodipine Besylate | 42 | $318 |
| Pravastatin Sodium | 42 | $291 |
| Oxcarbazepine | 11 | $285 |
| Omeprazole | 17 | $247 |
| Metoprolol Succinate | 13 | $247 |
| Pantoprazole Sodium | 21 | $202 |
| Levothyroxine Sodium | 30 | $199 |
| Atorvastatin Calcium | 45 | $197 |
| Losartan Potassium | 40 | $195 |
| Fluticasone Propionate | 11 | $176 |
| Allopurinol | 18 | $137 |
| Montelukast Sodium | 15 | $133 |
| Metformin Hcl | 18 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimCombivent Respimat | $80 | $7,19414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Findlay
- Thomas GraceFindlay$1.3M
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.